IDEAYA Biosciences, Inc. Shares Outstanding (Cover Page)
IDEAYA Biosciences, Inc. (IDYA) had Shares Outstanding (Cover Page) of 96.49 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 96.49M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 87.86M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 87.81M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 87.67M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 96.49M shares 10-Q · filed 2026-08-04 |
| 2026-05-01 | 87.86M shares 10-Q · filed 2026-05-05 |
| 2026-02-13 | 87.81M shares 10-K · filed 2026-02-17 |
| 2025-10-31 | 87.67M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 87.64M shares 10-Q · filed 2025-08-05 |
| 2025-05-02 | 87.58M shares 10-Q · filed 2025-05-06 |
| 2025-02-14 | 87.54M shares 10-K · filed 2025-02-18 |
| 2024-11-01 | 86.43M shares 10-Q · filed 2024-11-04 |
| 2024-08-02 | 84.48M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 75.69M shares 10-Q · filed 2024-05-07 |
| 2024-02-16 | 74.56M shares 10-K · filed 2024-02-20 |
| 2023-11-03 | 64.46M shares 10-Q · filed 2023-11-07 |
| 2023-08-04 | 57.56M shares 10-Q · filed 2023-08-10 |
| 2023-03-03 | 48.39M shares 10-K · filed 2023-03-07 |
| 2022-11-03 | 48.11M shares 10-Q · filed 2022-11-08 |
| 2022-08-09 | 39.31M shares 10-Q · filed 2022-08-15 |
| 2022-05-05 | 38.64M shares 10-Q · filed 2022-05-10 |
| 2022-03-14 | 38.63M shares 10-K · filed 2022-03-18 |
| 2021-11-08 | 38.50M shares 10-Q · filed 2021-11-15 |
| 2021-08-02 | 38.40M shares 10-Q · filed 2021-08-10 |
| 2021-05-03 | 32.91M shares 10-Q · filed 2021-05-10 |
| 2021-03-15 | 32.26M shares 10-K · filed 2021-03-23 |
| 2020-11-06 | 29.07M shares 10-Q · filed 2020-11-12 |
| 2020-08-03 | 29.03M shares 10-Q · filed 2020-08-12 |
| 2020-05-05 | 20.40M shares 10-Q · filed 2020-05-12 |
| 2020-03-13 | 20.34M shares 10-K · filed 2020-03-24 |
| 2019-11-01 | 20.33M shares 10-Q · filed 2019-11-13 |
| 2019-08-01 | 20.31M shares 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |